Showing results (31-40 of 52) with videos related to
Sort By:
Pageof 6
Cancer Immunology, Immunotherapy : CII|July 11, 2007
A polyvalent vaccine for high-risk prostate patients: "are more antigens better?"Susan F Slovin, Govind Ragupathi, Celina Fernandez, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 1, 2005
Multi-institutional randomized phase II trial of the epothilone B analog ixabepilone (BMS-247550) with or without estramustine phosphate in patients with progressive castrate metastatic prostate cancerMatthew D Galsky, Eric J Small, William K Oh, et al.Cancer|November 24, 2004
Society of Urologic Oncology position statement: redefining the management of hormone-refractory prostate carcinomaSam S Chang, Mitchell C Benson, Steven C Campbell, et al.Nanomedicine : Nanotechnology, Biology, and Medicine|June 15, 2013
Nanoparticles for urothelium penetration and delivery of the histone deacetylase inhibitor belinostat for treatment of bladder cancerDarryl T Martin, Christopher J Hoimes, Hristos Z Kaimakliotis, et al.Cancer|April 28, 2004
High-dose calcitriol, zoledronate, and dexamethasone for the treatment of progressive prostate carcinomaMichael J Morris, Oren Smaletz, David Solit, et al.The Journal of Urology|January 10, 2004
Feasibility of radical prostatectomy after neoadjuvant chemohormonal therapy for patients with high risk or locally advanced prostate cancer: results of a phase I/II studyBadrinath R Konety, James A Eastham, Vicor E Reuter, et al.International Journal of Radiation Oncology, Biology, Physics|February 8, 2020
Phase I Trial of Weekly Cabazitaxel with Concurrent Intensity Modulated Radiation and Androgen Deprivation Therapy for the Treatment of High-Risk Prostate CancerJianqing Lin, Robert B Den, Jacob Greenspan, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 5, 2014
Randomized controlled trial of early zoledronic acid in men with castration-sensitive prostate cancer and bone metastases: results of CALGB 90202 (alliance)Matthew R Smith, Susan Halabi, Charles J Ryan, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 17, 2007
Phase I trial of 17-allylamino-17-demethoxygeldanamycin in patients with advanced cancerDavid B Solit, S Percy Ivy, Catherine Kopil, et al.The Canadian Journal of Urology|June 21, 2023
Enhancing bladder cancer care through the multidisciplinary clinic approachJ Ryan Mark, Leonard G Gomella, Costas D Lallas, et al.Pageof 6